Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSinclair Pharma Regulatory News (SPH)

  • There is currently no data for SPH

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Completes £132m strategic disposal

17 Dec 2015 08:41

RNS Number : 3819J
Sinclair IS Pharma PLC
17 December 2015
 



 

Sinclair IS Pharma plc

("Sinclair" or the "Company")

Completes £132m strategic disposal of non-aesthetics business to Alliance Pharma plc

 

Creates a fast growth, high margin pure-play differentiated aesthetics company

 

· Delivering a product portfolio operating in fast growing markets underpinned by geographic expansion and new product introductions

· Highly differentiated aesthetics brands addressing unmet market need for effective, high quality, minimally-invasive treatments

· Simplified business structure with a strong balance sheet with pro forma net cash of £82m to support future growth

· The Company remains in an offer period

 

London, 17 December 2015 further to the announcement on 26 November 2015, Sinclair IS Pharma plc (SPH.L), ("Sinclair" or the "Company") the international specialty pharma company, is pleased to announce it has completed the strategic disposal of its non-aesthetics business to Alliance Pharma plc for a total upfront cash consideration of £132m as well as sales-related royalty payments relating to Flammacerium US.

 

The terms of the transaction announced on 26 November 2015 remain unchanged.

 

Sinclair is now a pure-play highly differentiated aesthetics company, operating in a high growth, self-pay market with high gross margin. Sinclair's balance sheet has now been transformed, leaving the Company with a pro-forma net cash position of £82m to invest in future growth opportunities and to cover milestone payments from historical acquisitions. Sinclair has built a strong portfolio of differentiated, complementary aesthetics technologies, which are experiencing significant growth, targeting unmet clinical needs for effective, high quality, longer duration, natural looking and minimally-invasive treatments. The Company is planning entry to multiple new geographic markets and line extension launches over the next few years.

 

As announced on 26 November 2015 the Company remains in an offer period under the framework provided by a formal sales process under the Takeover Code.

 

Tomorrow the Company will formally change its name to Sinclair Pharma plc, the TIDM will remain SPH.L.

 

For further information please contact:

 

Sinclair IS Pharma plc

Tel: +44 (0) 20 7467 6920

Chris Spooner

Alan Olby

 

Rothschild

Tel: +44 (0) 20 7280 5000

Julian Hudson

 

Peel Hunt LLP (NOMAD and Broker)

Tel: +44 (0) 20 7418 8900

James Steel

Oliver Jackson

 

Media enquiries

 

FTI Consulting

Tel: +44 (0) 203 727 1000

Ben Atwell

Brett Pollard

 

 

Notes to Editors:

 

About Sinclair IS Pharma plc - www.sinclairpharma.com 

Sinclair IS Pharma plc is an international company that operates in the fast growth, high gross margin, global aesthetics market. Sinclair has built a strong portfolio of differentiated, complementary aesthetics technologies, which are experiencing significant growth, targeting unmet clinical needs for effective, high quality, longer duration, natural looking and minimally-invasive treatments. The Company is planning entry to multiple new geographic markets and line extension launches over the next few years. The group has an established sales and marketing presence in the leading EU markets' and a rapidly growing International division concentrated on the Emerging Markets through long term multi-product, multi-country, sales, marketing and distribution deals with key strategic partners.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DISPKODNFBDKFBD
Date   Source Headline
18th Mar 20163:52 pmRNSRobert Stuart Swanson - Form 8.3 - Sinclair Pharma
18th Mar 201612:10 pmBUSForm 8.3 - Sinclair Pharma Plc
18th Mar 201611:02 amRNSForm 8.5 (EPT/RI) - Sinclair Pharma Plc
17th Mar 20163:13 pmRNSForm 8.3 - SINCLAIR PHARMA PLC
17th Mar 201610:42 amRNSForm 8.5 (EPT/RI) - Sinclair Pharma Plc
16th Mar 20163:08 pmRNSForm 8.3 - SINCLAIR PHARMA PLC
16th Mar 20168:32 amRNSForm 8.5 (EPT/RI) - Sinclair Pharma Plc
15th Mar 20162:53 pmRNSForm 8.3 - SINCLAIR PHARMA PLC
15th Mar 201611:36 amBUSForm 8.3 - Sinclair Pharma Plc
15th Mar 20167:30 amRNSForm 8.5 (EPT/RI) - Sinclair Pharma Plc
14th Mar 20161:34 pmRNSForm 8.3 - SINCLAIR PHARMA PLC
14th Mar 20168:45 amRNSForm 8.5 (EPT/RI) - Sinclair Pharma Plc
11th Mar 20163:22 pmRNSForm 8.3 - SINCLAIR PHARMA PLC
10th Mar 20168:43 amRNSForm 8.5 (EPT/RI) - Sinclair Pharma Plc
9th Mar 201611:59 amRNSForm 8.5 (EPT/RI) - Sinclair Pharma PLC
7th Mar 20169:56 amRNSForm 8.5 (EPT/RI) - Sinclair Pharma Plc
4th Mar 201611:59 amRNSForm 8.5 (EPT/RI) - Sinclair Pharma Plc
3rd Mar 201611:42 amRNSForm 8.5 (EPT/RI) - Sinclair Pharma Plc
2nd Mar 201611:25 amRNSForm 8.5 (EPT/RI) - Sinclair Pharma Plc
1st Mar 201610:20 amRNSForm 8.5 (EPT/RI) - Sinclair Pharma Plc
29th Feb 201611:12 amRNSForm 8.5 (EPT/RI) - Sinclair Pharma Plc
29th Feb 201611:11 amBUSForm 8.3 - Sinclair Pharma Plc
25th Feb 20162:07 pmRNSForm 8.3 - SINCLAIR PHARMA PLC
25th Feb 20161:34 pmRNSForm 8.3 - [Sinclair Pharma plc]
25th Feb 20169:40 amRNSForm 8.5 (EPT/RI) - Sinclair Pharma Plc
24th Feb 20163:13 pmRNSForm 8.3 - [Sinclair Pharma plc]
24th Feb 20168:47 amRNSForm 8.5 (EPT/RI) - Sinclair Pharma Plc
23rd Feb 201611:59 amRNSForm 8.5 (EPT/RI) - Sinclair Pharma Plc
19th Feb 20161:32 pmRNSForm 8.3 - [Sinclair Pharma plc]
19th Feb 20167:47 amRNSForm 8.5 (EPT/RI) - Sinclair Pharma Plc
18th Feb 20161:27 pmRNSForm 8.3 - [Sinclair Pharma plc]
18th Feb 201611:59 amRNSForm 8.5 (EPT/RI) - Sinclair Pharma Plc
17th Feb 201612:53 pmRNSForm 8.3 - [Sinclair Pharma plc]
17th Feb 201611:49 amBUSForm 8.3 - Sinclair Pharma Plc
17th Feb 20168:25 amRNSForm 8.5 (EPT/RI) - Sinclair Pharma Plc
15th Feb 20163:11 pmRNSForm 8.3 - [Sinclair Pharma plc]
15th Feb 201611:59 amRNSForm 8.5 (EPT/RI) - Sinclair Pharma Plc
12th Feb 20163:15 pmRNSForm 8.3 - [Sinclair Pharma plc]
12th Feb 201612:01 pmBUSForm 8.3 - Sinclair Pharma Plc
12th Feb 201611:59 amRNSForm 8.5 (EPT/RI) - Sinclair Pharma Plc
11th Feb 201611:59 amRNSForm 8.5 (EPT/RI) - Sinclair Pharma Plc
11th Feb 201610:54 amRNSHolding(s) in Company
10th Feb 20169:24 amRNSForm 8.5 (EPT/RI) - Sinclair Pharma Plc
9th Feb 20162:55 pmRNSForm 8.3 - [Sinclair Pharma plc]
9th Feb 201611:59 amRNSForm 8.5 (EPT/RI) - Sinclair Pharma Plc
8th Feb 20162:08 pmRNSForm 8.3 - [Sinclair Pharma plc]
8th Feb 20168:10 amRNSForm 8.5 (EPT/RI) - Sinclair Pharma Plc
5th Feb 20162:42 pmRNSForm 8.3 - [Sinclair Pharma plc]
5th Feb 201611:59 amRNSForm 8.5 (EPT/RI) - Sinclair Pharma Plc
4th Feb 20162:59 pmRNSForm 8.3 - [Sinclair Pharma plc]

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.